Signature Estate & Investment Advisors LLC Pfizer Inc Transaction History

Signature Estate & Investment Advisors LLC

$4.32 Billion
Q3 2024

A detailed history of Signature Estate & Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 18,836 shares of PFE stock, worth $501,414. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,836

Previous 21,394 11.96%

Holding current value

$501,414

Previous $598,000 8.86%

% of portfolio

0.01%

Previous 0.02%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $70,856 - $80,295	-2,558 Reduced 11.96%	18,836 $545,000
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $278,112 - $325,896	11,010 Added 106.03%	21,394 $598,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $5,825 - $6,689	-225 Reduced 2.12%	10,384 $288,000
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $55,761 - $72,427	-2,134 Reduced 16.75%	10,609 $305,000
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $834 - $975	-26 Reduced 0.2%	12,743 $423,000
Q2 2023 Jul 19, 2023	BUY	$36.12 - $41.79 $212,132 - $245,432	5,873 Added 85.17%	12,769 $468,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $7,090 - $9,230	180 Added 2.68%	6,896 $281,000
Q4 2022 Jan 11, 2023	BUY	$41.75 - $54.5 $13,986 - $18,257	335 Added 5.25%	6,716 $344,000
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $65,946 - $80,503	-1,507 Reduced 19.1%	6,381 $279,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $72,307 - $85,734	1,554 Added 24.53%	7,888 $413,000
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $99,140 - $122,847	-2,167 Reduced 25.49%	6,334 $328,000
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $702 - $1,041	17 Added 0.2%	8,501 $502,000
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $2,708 - $3,478	69 Added 0.82%	8,484 $365,000
Q2 2021 Jul 16, 2021	SELL	$35.91 - $40.68 $3,519 - $3,986	-98 Reduced 1.15%	8,415 $329,000
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $43,235 - $48,761	-1,291 Reduced 13.17%	8,513 $308,000
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $55,995 - $71,202	1,673 Added 20.58%	9,804 $361,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $34,258 - $40,192	1,079 Added 15.3%	8,131 $298,000
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $212,406 - $257,680	7,052 New	7,052 $231,000
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $193,372 - $276,287	-7,154 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $43,059 - $48,866	-1,308 Reduced 15.46%	7,154 $265,000
Q3 2019 Oct 09, 2020	SELL	$32.49 - $42.13 $47,597 - $61,720	-1,465 Reduced 14.76%	8,462 $304,000
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $160,403 - $207,995	4,937 Added 98.94%	9,927 $357,000
Q2 2019 Oct 09, 2020	SELL	$36.98 - $41.52 $45,670 - $51,277	-1,235 Reduced 19.84%	4,990 $216,000
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $34,798 - $39,070	941 Added 17.81%	6,225 $270,000
Q1 2019 Oct 13, 2020	BUY	$37.5 - $41.2 $3,750 - $4,120	100 Added 1.93%	5,284 $225,000
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $2,812 - $3,090	-75 Reduced 1.43%	5,184 $220,000
Q4 2018 Feb 01, 2019	BUY	$38.47 - $43.86 $12,118 - $13,815	315 Added 6.37%	5,259 $230,000
Q3 2018 Oct 18, 2018	BUY	$34.47 - $41.81 $30,092 - $36,500	873 Added 21.44%	4,944 $218,000
Q2 2018 Jul 24, 2018	SELL	$32.98 - $35.16 $21,272 - $22,678	-645 Reduced 13.68%	4,071 $148,000
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $44,067 - $51,124	-1,381 Reduced 22.65%	4,716 $167,000
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $9,046 - $9,598	272 Added 4.67%	6,097 $221,000
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $18,755 - $20,660	-605 Reduced 9.41%	5,825 $208,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,430	6,430 $216,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.

Account

Signature Estate & Investment Advisors LLC Pfizer Inc Transaction History